iShares Healthcare Innovation UCITS ETF
- ISIN
- IE00BYZK4776
- Base currency
- USD
- Currency hedged
- No
- Distributing
- No
- UCITS compliant
- Yes
- NAV as of 2022-06-24
- $7.27
- Annualized return rate
- 6.53% p.a. since inception
- Total NAV (USD)
- 1.3 billion
- Total expense ratio
- 0.4%
Investment strategy
The Fund seeks to track the performance of an index composed of developed and emerging market companies which are generating significant revenues from specific sectors focused on pushing the boundaries in medical treatment and technology
| Index | STOXX Global Breakthrough Healthcare Index |
|---|---|
| Structure | Physical |
| Currency hedged | No |
| Inception date | 2016-09-08 |
| Use of income | Accumulating |
|---|---|
| Distribution frequency | – |
| Domicile | Ireland |
Asset classes
| Name | % |
|---|---|
|
Equity
|
100% |
|
Cash
|
0% |
|
Cash Collateral and Margins
|
0% |
Sectors
| Name | % |
|---|---|
|
Health Care
|
99% |
|
Information Technology
|
1% |
|
Cash and/or Derivatives
|
0% |
|
Materials
|
0% |
Locations
| Name | % |
|---|---|
|
United States
|
72% |
|
Korea (South)
|
5% |
|
Switzerland
|
4% |
|
Japan
|
4% |
|
Belgium
|
3% |
|
Germany
|
2% |
|
China
|
2% |
|
Denmark
|
2% |
|
Australia
|
1% |
|
France
|
1% |
|
Sweden
|
1% |
|
Italy
|
1% |
|
United Kingdom
|
0% |
|
Canada
|
0% |
|
Spain
|
0% |
|
Taiwan
|
0% |
|
India
|
0% |
| Name | Asset class | Sector | Location | Weight |
|---|---|---|---|---|
|
S
Seagen Inc
US81181C1045
|
Equity | Health Care | United States | 1.58% |
|
A
ARGENX
NL0010832176
|
Equity | Health Care | Belgium | 1.39% |
|
M
Moderna Inc
US60770K1079
|
Equity | Health Care | United States | 1.37% |
|
M
Merck & Company Inc
US58933Y1055
|
Equity | Health Care | United States | 1.34% |
|
B
Biogen Inc
US09062X1037
|
Equity | Health Care | United States | 1.34% |
|
A
AbbVie Inc
US00287Y1091
|
Equity | Health Care | United States | 1.32% |
|
G
Gilead Sciences Inc
US3755581036
|
Equity | Health Care | United States | 1.31% |
|
B
Bristol-Myers Squibb Company
US1101221083
|
Equity | Health Care | United States | 1.31% |
|
G
Genmab A/S
DK0010272202
|
Equity | Health Care | Denmark | 1.31% |
|
T
Thermo Fisher Scientific Inc
US8835561023
|
Equity | Health Care | United States | 1.29% |
| Ex-date | Record date | Payment date | Dividend per share |
|---|
| Ticker | MIC | Currency |
|---|---|---|
| HEAL | XLON | USD |
| HEAL | XAMS | EUR |
| HEAL | XETR | EUR |
| DRDR | XLON | GBP |
| HEAL | XMEX | MXN |
| HEAL | XMIL | EUR |
| HEAL | XSWX | USD |
| 1159128 | XTAE | ILS |